Of 212 patients with spinal TB treated between January 1999 and June 2011, 179 patients were included in the study (¡Ý6 months follow-up; mean age, 34.8 years; age range, 10-75 years). The cohort was divided into two groups (n?= 89 and n?= 90); group I was treated from 1999-2003, and group II was treated from 2004-2011.
The study cohort comprised 93 male patients. Mean age was 34.8 years ¡À 7.2 (range, 10-75 years). Mean duration of symptoms was 2.4 months. Sensorimotor deficits were present in 167 patients (93.5 % ; 74 patients were paraplegic), pain was present in 156 patients (87 % ), bladder involvement was present in 127 patients (71.7 % ), and extraspinal TB was present in 36 patients (22.3 % ). Of patients, 92 % were receiving prior chemotherapy; one fifth of these patients were on second-line chemotherapy. Thoracic spine involvement was most common (n?= 86; 57 % ), followed by cervical spine (n?= 50; 29 % ), craniovertebral junction (n?= 22; 15 % ), and lumbosacral spine (n?= 20; 10.5 % ). Surgery was performed in 146 patients (68 % instrumented fusions and 16 % circumferential fusions). Mean follow-up was 20.2 months (range, 6-60 months). Sensorimotor deficits improved in 89 % of patients, pain improved in 71 % , bladder symptoms improved in 88 % , and paraplegia improved in 77 % . Patients in group II had a higher incidence of cord compression (P < 0.01), severe vertebral body collapse (P < 0.001), and paraplegia (P < 0.001). Group II patients underwent more instrumented surgeries (P < 0.01), especially circumferential fusions (P < 0.001). The improvement in paraplegia was better after 2004 (group II). Bladder symptoms correlated with the timing of surgery (P < 0.1).
Medical treatment of spinal TB is the mainstay; however, radical, instrumented surgeries should be offered when indicated. The presence of paraplegia should not preclude surgery. A practical management paradigm is also suggested.